Eyenovia, Inc..
EYEN.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Eyenovia, Inc. is a commercial-stage ophthalmic pharmaceutical company. It focuses on developing and commercializing a pipeline of microdose therapeutics utilizing its Optejet platform. The Optejet is a piezo-print micro-formulation delivery technology. The company's lead product candidate is MydCom...Show More
Better Health for All
0
No evidence available to assess Eyenovia, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
Eyenovia, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic therapeutics. Its primary activity is the research, development, and commercialization of pharmaceutical products for eye conditions. The company's business model does not involve lending, insuring, moving, or storing money for consumers. Therefore, all KPIs related to fair money and economic opportunity, which are specific to financial services, are not applicable to Eyenovia's operations. The provided articles discuss the company's financial performance, capital raising, and product development, but contain no information relevant to these financial services-specific metrics.
Fair Pay & Worker Respect
0
No evidence available to assess Eyenovia, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No evidence available to assess Eyenovia, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess Eyenovia, Inc. on Honest & Fair Business.
Kind to Animals
0
No specific, concrete data points were found in the provided articles regarding Eyenovia's performance on any of the 'Kind to Animals' KPIs. The articles discuss Eyenovia's business operations and general information about alternatives to animal testing, but do not provide evidence of the company's policies, practices, or metrics related to animal welfare, testing, or sourcing.
No War, No Weapons
0
Eyenovia, Inc. is an ophthalmic pharmaceutical company. The provided articles, including those detailing its digital asset treasury strategy, do not contain any information or specific data points regarding the company's involvement in arms manufacturing, military contracts, dual-use technologies with military applications, sales to embargoed regimes, or any peacebuilding initiatives.
1
Therefore, there is no evidence to assess the company against the 'No War, No Weapons' ethical value or its associated KPIs.
Planet-Friendly Business
-20
In 2023, Eyenovia, Inc. reported total Scope 1 and 2 emissions of 627 metric tons CO2e.
1
The company achieved a waste diversion rate of 22% in 2023.
2
Eyenovia reported zero environmental compliance violations in 2023.
3
Respect for Cultures & Communities
0
No specific, concrete data points or facts were found in the provided articles regarding Eyenovia's performance on any of the KPIs related to Respect for Cultures & Communities.
1
The articles discuss business operations, product development, regulatory approvals, and workforce changes, but do not contain information on community partnerships, cultural impact assessments, local employment, grievance mechanisms, or cultural preservation efforts.
2
Safe & Smart Tech
0
No evidence available to assess Eyenovia, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No evidence available to assess Eyenovia, Inc. on Zero Waste & Sustainable Products.